<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
  <title>Retatrutide SA: articles</title>
  <link>https://retatrutidesouthafrica.co.za/articles</link>
  <atom:link href="https://retatrutidesouthafrica.co.za/feed.xml" rel="self" type="application/rss+xml"/>
  <description>Articles on retatrutide, GLP-1 medicines and related peptides, for readers in South Africa.</description>
  <language>en-za</language>
  <lastBuildDate>Tue, 06 Oct 2026 09:30:00 GMT</lastBuildDate>
  <item>
    <title>GLP-1 drug crackdown and new payment options in South Africa</title>
    <link>https://retatrutidesouthafrica.co.za/articles/glp-1-south-africa</link>
    <guid isPermaLink="true">https://retatrutidesouthafrica.co.za/articles/glp-1-south-africa</guid>
    <pubDate>Tue, 06 Oct 2026 09:30:00 GMT</pubDate>
    <category>News</category>
    <description>South Africa’s crackdown on illegal GLP-1 compounding and the rise of buy-now-pay-later schemes for weight-loss medicines.</description>
  </item>
  <item>
    <title>Is retatrutide legal in South Africa?</title>
    <link>https://retatrutidesouthafrica.co.za/articles/is-retatrutide-legal-in-south-africa</link>
    <guid isPermaLink="true">https://retatrutidesouthafrica.co.za/articles/is-retatrutide-legal-in-south-africa</guid>
    <pubDate>Wed, 30 Sep 2026 09:30:00 GMT</pubDate>
    <category>Regulation</category>
    <description>Retatrutide is not registered by SAHPRA. What the regulator has said, what the trials show, and when it could reach South Africa.</description>
  </item>
  <item>
    <title>SAHPRA-approved GLP-1 medicines in South Africa: the 2026 list</title>
    <link>https://retatrutidesouthafrica.co.za/articles/sahpra-approved-glp-1-medicines</link>
    <guid isPermaLink="true">https://retatrutidesouthafrica.co.za/articles/sahpra-approved-glp-1-medicines</guid>
    <pubDate>Wed, 30 Sep 2026 09:30:00 GMT</pubDate>
    <category>GLP-1 medicines</category>
    <description>Every GLP-1 and GIP/GLP-1 medicine on the SAHPRA register as of September 2026, the new generic semaglutides, and their prices.</description>
  </item>
</channel>
</rss>
